Abstract LB340: Mechanism-based trial matching reveals a 54% target alignment gap in ovarian cancer: Quantifying the precision-eligible ovarian cancer patients
F Kiani · Cancer Research 86 (8_Supplement), LB340-LB340, 2026
Read morePublished
CRISPRO · KNOWLEDGE BASE
Back to ResearchAACR and conference abstracts — open slides on-site or the published citation.
Local seedF Kiani · Cancer Research 86 (8_Supplement), LB340-LB340, 2026
F Kiani · Cancer Research 86 (7_Supplement), 2235-2235, 2026
F Kiani, SA Allah · Cancer Research 86 (6_Supplement), B065-B065, 2026
F Kiani, SA Allah · Cancer Immunology Research 14 (2_Supplement), LB-B013-LB-B013, 2026
F Kiani, R Nayeem · Cancer Immunology Research 13 (9_Supplement), B025-B025, 2025